| Pharmaceutical Information |
| Drug Name |
Atracurium besylate |
| Drug ID |
BADD_D00188 |
| Description |
A non-depolarizing neuromuscular blocking agent with short duration of action. Its lack of significant cardiovascular effects and its lack of dependence on good kidney function for elimination provide clinical advantage over alternate non-depolarizing neuromuscular blocking agents. |
| Indications and Usage |
For use, as an adjunct to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. |
| Marketing Status |
approved |
| ATC Code |
M03AC04 |
| DrugBank ID |
DB00732
|
| KEGG ID |
D00758
|
| MeSH ID |
D001279
|
| PubChem ID |
47320
|
| TTD Drug ID |
D0Q1PR
|
| NDC Product Code |
55150-216; 0409-1105; 0409-1109; 71288-701; 55486-1597; 71288-702; 55150-217; 17404-0008 |
| UNII |
40AX66P76P
|
| Synonyms |
Atracurium | 33 A 74 | A 74, 33 | Relatrac | Tracrium | BW-33A | BW 33A | BW33A | Atracurium Besylate | Atracurium Besilate | Besilate, Atracurium | Atracurium Dibesylate |
|
| Chemical Information |
| Molecular Formula |
C65H82N2O18S2 |
| CAS Registry Number |
64228-81-5 |
| SMILES |
C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CC
C5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C
=C1)S(=O)(=O)[O-] |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
